Analytical Data
-
Gene name
Rv3304
- Application
-
Species
Mycobacterium tuberculosis
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O53356
-
Expression Region
1-159aa
-
Molecular Weight
24.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Rv3304, a protein encoded by the Mycobacterium tuberculosis genome, has garnered significant attention due to its potential role in the pathogenicity and survival of the bacteria within the host. As a major global health threat, tuberculosis remains one of the leading causes of death related to infectious diseases, necessitating research into novel therapeutic targets. The Rv3304 protein is implicated in various cellular processes, including metabolism and stress response, which are critical for the bacterium's adaptation to hostile environments within the host immune response. Understanding the structure, function, and interaction of Rv3304 with other cellular components could unveil new insights into the mechanisms of virulence and resistance in M. tuberculosis. Furthermore, its potential as a vaccine candidate or drug target highlights the importance of investigating Rv3304 in the context of tuberculosis research. Recent studies involving the recombinant expression of Rv3304 aim to elucidate its biological functions and assess its immunogenic properties, paving the way for innovative strategies in the treatment and prevention of tuberculosis. Such research endeavors are crucial for developing effective interventions against this enduring infectious disease, particularly in the face of rising drug resistance.
